Publications

View and download slide summaries of the latest original articles focusing on therapies in immune-mediated inflammatory diseases including rheumatology, dermatology, and gastroenterology. All materials produced by the team are subsequently reviewed and approved by individual Steering Committee members.

October 2022

Venous Thromboembolism with JAK Inhibitors and Other Immune-Modulatory Drugs: a Swedish Comparative Safety Study Among Patients with Rheumatoid Arthritis

Ann Rheum Dis. 2022. doi: 10.1136/ard-2022-223050

Bower H,

Nationwide register-based study in Sweden finds that patients with RA treated with JAKinibs in routine clinical practice are at increased risk of venous thromboembolism (VTE), compared with those treated with bDMARDs, an increase numerically confined to pulmonary embolism.

Keywords:

June 2022

Rischi di cancro a breve e lungo termine con farmaci antireumatici modificanti la malattia biologici e sintetici utilizzati contro l'artrite reumatoide nella pratica clinica

Rheumatology (Oxford) 2022 doi: 10.1093/rheumatology/keab570

Huss V,

Bower H,

Wadström H,

Frisell T,

Askling J; ARTIS group

Observational, nationwide cohort study finds no increased risk for cancer overall in RA patients treated with TNFis, anti-CD20 or anti-IL6.